123 Main Street, New York, NY 10001

Top Navigation with Mega Menu
Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(0.87)
Shares Outstanding31.9M
Average Volume (10 days)73.0K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.25)
Sales (TTM)$0.21
Book Value (MRQ)$2.27
Cash Flow (TTM)($0.79)
Cash (MRQ)$1.49

Analyst Views

Current Mean RecommendationHold
Strong Buy0
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Dwight Egan
Chief Executive Officer
138,333
Acquire
May 23, 2024
Dwight Egan
Chief Executive Officer
(42,008)
Dispose
May 23, 2024
Serbin Richard
Director
30,000
Acquire
May 23, 2024
Murphy Ted
Director
30,000
Acquire
May 23, 2024
Brian Lee Brown
Chief Financial Officer
113,334
Acquire
May 23, 2024

Recent SEC Filings

Company Events
Aug 30, 2024
Company Events
Aug 8, 2024
Quarterly Financials
Aug 8, 2024
Proxy Statement
Jul 16, 2024
Company Events
Jun 14, 2024

Join Our Newsletter

Receive our latest blog posts directly in your inbox!